Nu-Tek BioSciences Inks Pact with IMCD for Distribution

India Pharma Outlook Team | Wednesday, 05 June 2024

 pharmaceutical development, global distribution, India Pharma Outlook

Nu-Tek BioSciences is an innovative developer of crucial raw materials used in cell culture media for pharmaceutical development and production. Nu-Tek has signed an agreement with IMCD to distribute its peptones and hydrolysates throughout Europe and Asia Pacific. The partnership broadens Nu-Tek's reach and reinforces its position as the market leader in animal-free ingredients. As a major global distribution partner and manufacturer of specialty chemicals and ingredients, IMCD allows Nu-Tek to service local clients while growing the IMCD product portfolio.

About the recent agreement, IMCD’s Director of Agrochemicals & Biopharma, Michal Archman shared that “We are delighted to embark on this partnership journey with Nu-Tek Biosciences, as our shared long-term aspirations and strategic alignment make us the perfect fit. Together, our goal is to broaden the array of companies engaged in cell culture and precision fermentation, offering animal-origin-free products that excel in functionality. With the combination of our extensive geographical reach and Nu-Tek’s product expertise, we strongly believe in the significant global potential of this endeavour.”

Nu-Tek BioSciences, a bitotechnology firm which is the global leader for animal-free peptones and hydrolysates. Nu-Tek, which has a greenfield state-of-the-art production plant, is well positioned to meet the long-term demands of biologics worldwide. Nu-Tek works with customers around the world to reduce variability and boost production by using automation to compile data in real time.

© 2024 India Pharma Outlook. All Rights Reserved.